471
Views
8
CrossRef citations to date
0
Altmetric
Review Article

Overview of treatment options for invasive fungal infections

, , , &
Pages 561-580 | Received 22 Nov 2010, Accepted 31 Jan 2011, Published online: 03 Mar 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (8)

Scott W. Mueller, Sonya K. Kedzior, Matthew A. Miller, Paul M. Reynolds, Tyree H. Kiser, Martin Krsak & Kyle C. Molina. (2021) An overview of current and emerging antifungal pharmacotherapy for invasive fungal infections. Expert Opinion on Pharmacotherapy 22:10, pages 1355-1371.
Read now
Rie Ueno, Shinichi Nishimura, Go Fujimoto & Dilinuer Ainiwaer. (2021) Healthcare resource utilization and economic burden of antifungal management in patients with hematologic malignancy in Japan: a retrospective database study. Current Medical Research and Opinion 37:7, pages 1121-1134.
Read now
Ioannis Kyriakidis, Athanasios Tragiannidis, Silke Munchen & Andreas H. Groll. (2017) Clinical hepatotoxicity associated with antifungal agents. Expert Opinion on Drug Safety 16:2, pages 149-165.
Read now
David Allen, Dustin Wilson, Richard Drew & John Perfect. (2015) Azole antifungals: 35 years of invasive fungal infection management. Expert Review of Anti-infective Therapy 13:6, pages 787-798.
Read now
Athanasios Tragiannidis, Christos Tsoulas, Kornelius Kerl & Andreas H Groll. (2013) Invasive candidiasis: update on current pharmacotherapy options and future perspectives. Expert Opinion on Pharmacotherapy 14:11, pages 1515-1528.
Read now
Rita Semis, Sarah Kagan, Israela Berdicevsky, Itzhack Polacheck & Esther Segal. (2013) Mechanism of activity and toxicity of Nystatin-Intralipid. Medical Mycology 51:4, pages 422-431.
Read now
David Andes. (2013) Optimizing antifungal choice and administration. Current Medical Research and Opinion 29:sup4, pages 13-18.
Read now
Aditya K Gupta & Fiona C Simpson. (2012) New therapeutic options for onychomycosis. Expert Opinion on Pharmacotherapy 13:8, pages 1131-1142.
Read now

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.